Fosun International’s Impax Laboratories, Inc. IPXL Stock Holding History

Fosun International’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,854,995	Closed	-$75M	–	95
2018 Q1	$75M	Hold	3,854,995	–	–	4.72%	6
2017 Q4	$64.2M	Hold	3,854,995	–	–	5.63%	4
2017 Q3	$78.3M	Buy	3,854,995 +3,554,995	+1,185%	+$68M	7.78%	4
2017 Q2	$4.83M	Hold	300,000	–	–	0.6%	23
2017 Q1	$3.79M	Buy	+300,000	New	+$3.62M	0.47%	21

Fosun International's IPXL Position: Q2 2018 in Review

Fosun International sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 3,854,995 shares — an estimated $75M sold.

Fosun International first reported a position in IPXL in Q1 2017 and held it in 5 quarters. The position peaked at $78.3M in Q3 2017. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Fosun International reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Fosun International sold 3,854,995 Impax Laboratories, Inc. shares in Q2 2018, an estimated $75M.
Fosun International first reported a position in Impax Laboratories, Inc. in Q1 2017 and held it in 5 quarters.
Fosun International's Impax Laboratories, Inc. position peaked at $78.3M in Q3 2017.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Fosun International's 13F filing for Q2 2018, filed 13 Aug 2018.